Abacus Global Management
ABX · NYSE
About ABX
- Employees
- 326
- Headquarters
- Orlando, Florida
- Listed
- Jul 23, 2020
- Sector
- Financials
- Industry
- Insurance
- Website
- abacusgm.com
ABX key statistics
- Market cap
- 820.48M
- Price-earnings ratio
- 29.07
- Dividend yield
- 2.44%
- Average volume
- 672.03K
- Volume
- 899.72K
- Open price
- $7.90
- High today
- $8.43
- Low today
- $7.83
- 52 Week high
- $12.44
- 52 Week low
- $5.00
Abacus Global Management (ABX) at a glance
Abacus Global Management (ABX) last traded at $8.39, with a market cap of 820.48M, a price-to-earnings ratio of 29.07 and a dividend yield of 2.44%.
Today the stock has traded between $7.83 and $8.43. The current price is 7.2% above the day's low and 0.5% below its high.
Volume so far is 899.72K shares, above the average of 672.03K shares a day.
Over the past year Abacus Global Management has ranged from $5.00 to $12.44, and now sits 46% of the way up that range.
Abacus Global Management met or beat analyst EPS estimates in 7 of the last 8 quarters. In Q2 FY26 it reported $0.28 per share against an estimate of $0.2418.
The average analyst price target is $14.64, 74.5% above the current price, from 1 recent ratings.
Analyst ratings
Latest rating from each analyst over the past 12 months
- Buy0.0%
- Hold100.0%
- Sell0.0%
- Low
- $12.12
- Now
- $8.39
- High
- $16.80
ABX earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 7 of the last 8 quarters, by 21.2% on average.
- Q3 FY24: reported $0.20 per share against an estimate of $0.1366
- Q4 FY24: reported $0.16 per share against an estimate of $0.1399
- Q1 FY25: reported $0.18 per share against an estimate of $0.1596
- Q2 FY25: reported $0.22 per share against an estimate of $0.1656
- Q3 FY25: reported $0.20 per share against an estimate of $0.1858
- Q4 FY25: reported $0.23 per share against an estimate of $0.1939
- Q1 FY26: reported $0.21 per share against an estimate of $0.2101
- Q2 FY26: reported $0.28 per share against an estimate of $0.2418
ABX news
- Press releaseBusiness Wire
- Press releaseBusiness Wire
Abacus Global Management and Retirable Announce Partnership, Integrating Abacus LifeARC™ into Retirable Platform
- Press releaseBusiness Wire
Abacus Global Management to Participate in Virtual Fireside Chat Hosted by Autonomous Research
- Press releaseBusiness Wire
Abacus Founders Elect to Retain Substantial Ownership, Terminate 10b5-1 Trading Plans
- Press releaseBusiness Wire
Abacus Global Management Completes Landmark $400 Million Securitization
- Press releaseBusiness Wire
Abacus Global Management to Participate in the Barclays 24th Annual Global Financial Services Conference
- Press releaseBusiness Wire
Abacus Global Management Publishes CIO Analysis on Discount Rate Trends and Updated Valuation Methodology
- Press releaseBusiness Wire
Citing Continued Pattern of Misleading and Defamatory Statements, Abacus Moves to Amend Complaint and Seek Increased Damages Against Coventry and its Chairman, Alan Buerger
Similar companies
Companies in the same industry as Abacus Global Management
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- SDSTStardust Power$0.02−23.66%
- SHFSSHF Holdings$0.0899−4.36%
- FRTTFort Technology$0.7121+32.63%
- CBDLCBD Life Sciences$0.0002−25.00%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.